Apr 26, 2019
Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
| Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| President & CEO: | Tatsuro Kosaka |
| Inquiries to: | Masahiko Uchida, General Manager, |
| Corporate Communications Dept. | |
| Tel:+81-(0)3-3273-0881 |
Chugai Pharmaceutical Co., Ltd. announces that, disposal of treasury shares was completed on April 26, 2019, as we announced in the press release “Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan” on March 28, 2019. The result of treasury shares are as follows.
Overview of Disposal
| (1) | Disposal date | April 26, 2019 | ||
| (2) | Class and number of disposed shares | 42,900 shares of Common stock of the Company | ||
| (3) | Disposal price | ¥7,700 per share | ||
| (4) | Total value of disposed shares | ¥330,330,000 | ||
| (5) | Allottees and number thereof, and number of disposed shares; | Directors | 3 | 22,300 shares |
| Vice presidents | 18 | 10,400 shares | ||
| Employees | 94 | 10,200 shares | ||
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Tomoko Shimizu
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Toshiya Sasai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
